Pyrazinamide 500mg is a powerful first-line antituberculosis (anti-TB) medication, primarily used as a critical component of short-course combination therapy. It is specifically indicated for the initial treatment phase of both pulmonary and extrapulmonary tuberculosis to ensure the complete eradication of the infection.
What makes Pyrazinamide essential is its unique “sterilizing” action. It effectively targets and eliminates semi-dormant Mycobacterium tuberculosis bacteria that reside in acidic environments, such as inside the body’s immune cells. By killing these stubborn bacteria during the first two months of treatment (the intensive phase), Pyrazinamide plays a vital role in shortening the overall duration of therapy and significantly reducing the risk of relapse.
Key Benefits:
-
Essential 1st-Line Treatment: A cornerstone of the WHO-recommended DOTS (Directly Observed Treatment, Short-course) program.
-
Targeted Sterilizing Action: Effectively kills semi-dormant bacteria that other TB drugs might miss.
-
Shortens Treatment Duration: Vital for reducing the total time required for TB therapy when used in the intensive phase.
-
Prevents Relapse: By eradicating persistent bacteria, it helps ensure long-term recovery and prevents the return of symptoms.
-
Supports Public Health: Helps stop the transmission of TB by rapidly reducing the bacterial load in the patient.




